Alpharma gets $95 million revolver

By Sara Rosenberg

New York, Dec. 13 - Alpharma ApS, a wholly owned, indirect subsidiary of Alpharma Inc., closed on a new $95 million multicurrency revolving credit facility due 2008, according to an 8-K filed with the Securities and Exchange Commission Tuesday.

DnB NOR Bank is the lead bank on the deal that closed Dec. 7.

Borrowings will be used for general corporate purposes, including working capital and capital expenditures.

Alpharma Inc. is a Fort Lee, N.J., pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.